Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

P. Kongtim, K. Adekola, D. R. Milton, R. Ramlal, A. Jimenez, J. Chen, G. Rondon, S. Ahmed, P. Kebriaei, O. Betul, C. M. Hosing, U. Popat, I. Khouri, E. Jabbour, J. E. Cortes, H. M. Kantarjian, R. E. Champlin, S. O. Ciurea

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)1654-1657
Number of pages4
JournalLeukemia
Volume31
Issue number7
DOIs
StatePublished - Jul 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors. / Kongtim, P.; Adekola, K.; Milton, D. R.; Ramlal, R.; Jimenez, A.; Chen, J.; Rondon, G.; Ahmed, S.; Kebriaei, P.; Betul, O.; Hosing, C. M.; Popat, U.; Khouri, I.; Jabbour, E.; Cortes, J. E.; Kantarjian, H. M.; Champlin, R. E.; Ciurea, S. O.

In: Leukemia, Vol. 31, No. 7, 01.07.2017, p. 1654-1657.

Research output: Contribution to journalLetter

Kongtim, P, Adekola, K, Milton, DR, Ramlal, R, Jimenez, A, Chen, J, Rondon, G, Ahmed, S, Kebriaei, P, Betul, O, Hosing, CM, Popat, U, Khouri, I, Jabbour, E, Cortes, JE, Kantarjian, HM, Champlin, RE & Ciurea, SO 2017, 'Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors', Leukemia, vol. 31, no. 7, pp. 1654-1657. https://doi.org/10.1038/leu.2017.118
Kongtim, P. ; Adekola, K. ; Milton, D. R. ; Ramlal, R. ; Jimenez, A. ; Chen, J. ; Rondon, G. ; Ahmed, S. ; Kebriaei, P. ; Betul, O. ; Hosing, C. M. ; Popat, U. ; Khouri, I. ; Jabbour, E. ; Cortes, J. E. ; Kantarjian, H. M. ; Champlin, R. E. ; Ciurea, S. O. / Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors. In: Leukemia. 2017 ; Vol. 31, No. 7. pp. 1654-1657.
@article{8dcc3a7219c14582bc7c9ed474baba05,
title = "Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors",
author = "P. Kongtim and K. Adekola and Milton, {D. R.} and R. Ramlal and A. Jimenez and J. Chen and G. Rondon and S. Ahmed and P. Kebriaei and O. Betul and Hosing, {C. M.} and U. Popat and I. Khouri and E. Jabbour and Cortes, {J. E.} and Kantarjian, {H. M.} and Champlin, {R. E.} and Ciurea, {S. O.}",
year = "2017",
month = "7",
day = "1",
doi = "10.1038/leu.2017.118",
language = "English (US)",
volume = "31",
pages = "1654--1657",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

AU - Kongtim, P.

AU - Adekola, K.

AU - Milton, D. R.

AU - Ramlal, R.

AU - Jimenez, A.

AU - Chen, J.

AU - Rondon, G.

AU - Ahmed, S.

AU - Kebriaei, P.

AU - Betul, O.

AU - Hosing, C. M.

AU - Popat, U.

AU - Khouri, I.

AU - Jabbour, E.

AU - Cortes, J. E.

AU - Kantarjian, H. M.

AU - Champlin, R. E.

AU - Ciurea, S. O.

PY - 2017/7/1

Y1 - 2017/7/1

UR - http://www.scopus.com/inward/record.url?scp=85021762137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021762137&partnerID=8YFLogxK

U2 - 10.1038/leu.2017.118

DO - 10.1038/leu.2017.118

M3 - Letter

C2 - 28400618

AN - SCOPUS:85021762137

VL - 31

SP - 1654

EP - 1657

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 7

ER -